Recommendations and Alerting for Delirium Alleviation in Real-Time (RADAR)
Primary Purpose
Delirium
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Family Support System
HELP Support System
Sponsored by
About this trial
This is an interventional treatment trial for Delirium focused on measuring Caregivers, Clinical Decision Support Systems, Cognitive Dysfunction, Confusion, Delirium, Feasibility Studies, Geriatric Assessment, Neurocognitive Disorders
Eligibility Criteria
Inclusion Criteria:
- Age ≥ 70 years of age
- Major non-cardiac, non-intracranial neurologic, and non-major vascular surgery
- Anticipated length of stay at least 72 hours
- At least one family member, or caretaker, available on each of the first three postoperative days for trial operations
Exclusion Criteria:
- Emergency surgery
- Severe cognitive impairment (precluding ability to perform delirium assessments)
- Planned postoperative ICU admission
- Non-English speaking
Sites / Locations
- University of Michigan Medical School
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Arm Type
No Intervention
Experimental
Experimental
Experimental
Arm Label
Usual Care Group
HELP Support System
Family Support System
Combined Support Systems
Arm Description
Usual care per surgical ward standards
This arm will receive the HELP Support System intervention only
This arm will receive the Family Support system intervention only
Participants randomized to this arm will receive both HELP- and family-based support system interventions
Outcomes
Primary Outcome Measures
Delirium
Any positive delirium screen (yes/no) as determined by the long-form Confusion Assessment Method (n, 0-19)
Secondary Outcome Measures
Delirium Severity
For any patient with a positive delirium assessment, the associated severity score will be recorded using the Confusion Assessment Method Long Form Severity Score (n, 0-19, with higher number indicating more severe delirium)
Depressive symptoms as assessed by Hospitalized Anxiety and Depression Scale (HADS-D)
Incidence (%) of positive screens (score ≥8) using the Hospitalized Anxiety and Depression Scale (HADS-D) (n, 0-21, 0 = normal, 21 = presence of severe depression symptoms)
Anxiety symptoms as assessed by Hospitalized Anxiety and Depression Scale (HADS-A)
Incidence (%) of positive screens (score ≥8) using the Hospitalized Anxiety and Depression Scale (HADS-A) (n, 0-21, 0 = normal, 21 = presence of severe anxiety symptoms)
Falls
Proportion of patients in each group (%) experiencing at least one fall
Length of Hospital Stay
Total number of days (n) spent in the hospital, up to 30 days
Discharge Disposition
Proportion of patients in each group (%) discharged somewhere other than home (e.g., Long-Term Care Facility), up to 30 days
Delayed Discharge - Cognitive Impairment
Proportion of patients in each group (%) experiencing delayed discharge, with the documented reason as cognitive impairment
New non-surgical site infection
Incidence (%) of any new non-surgical site infection while hospitalized
Multidrug resistant organism colonization
Incidence (%) of any new multidrug resistant organism colonization
Mortality
Incidence (%)
Full Information
NCT ID
NCT04007523
First Posted
June 27, 2019
Last Updated
October 8, 2022
Sponsor
University of Michigan
Collaborators
The Claude D. Pepper Older Americans Independence Centers
1. Study Identification
Unique Protocol Identification Number
NCT04007523
Brief Title
Recommendations and Alerting for Delirium Alleviation in Real-Time (RADAR)
Official Title
Recommendations and Alerting for Delirium Alleviation in Real-Time (RADAR): a Pilot Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
October 2022
Overall Recruitment Status
Completed
Study Start Date
November 21, 2019 (Actual)
Primary Completion Date
July 27, 2022 (Actual)
Study Completion Date
July 27, 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Michigan
Collaborators
The Claude D. Pepper Older Americans Independence Centers
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This is a pilot randomized controlled trial that will test whether a multicomponent decision support system will improve the postoperative environment for neurocognitive and clinical recovery in older, high-risk surgical patients. Decision support systems will be tested that provide targeted alerts and recommendations to the Hospital Elder Life Program and family members for delirium prevention.
Detailed Description
Delirium is a distressing and common surgical complication, affecting approximately 20-50% of older surgical patients. Postoperative delirium is associated with increased mortality, cognitive and functional decline, and healthcare resource utilization. Prevention programs have been tested with variable success, but the Hospital Elder Life Program (HELP) has consistently been demonstrated to reduce the incidence and impact of delirium. However, substantial resources are needed for program operations, and complementary support systems may help with patient triage and assessment. Family members and caretakers may be able to provide supplementary support with delirium screening and prevention via targeted, therapeutic activities. Thus, an automated postoperative paging system, which elicits additional, focused support from HELP and family members, may augment delirium prevention activities and reduce associated risk.
The primary objectives of this study are to determine whether pager-based clinical decision support systems bolster HELP- and family-based therapeutic activities. A secondary objective will be to identify facilitators and barriers to delivering therapeutic interventions for both HELP and family members. Overall, this pilot trial will test the hypothesis that a multicomponent decision support system will improve the postoperative environment for neurocognitive and clinical recovery in older, high-risk surgical patients. Patients (n=60) will be randomized to one of four groups in a factorial design: usual care (n=15), HELP-based paging system (n=15), family-based paging system (n=15), or both HELP- and family-based paging system (n=15). The support systems will consist of automated pager alerts to the HELP program and/or family members and caretakers, depending on group allocation, for providing additional delirium evaluation and therapeutic prevention activities. Outcomes will include various clinical, neurocognitive, and functional measures, and performance metrics will be collected regarding HELP- and family-based interventions.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Delirium
Keywords
Caregivers, Clinical Decision Support Systems, Cognitive Dysfunction, Confusion, Delirium, Feasibility Studies, Geriatric Assessment, Neurocognitive Disorders
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Factorial Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
60 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Usual Care Group
Arm Type
No Intervention
Arm Description
Usual care per surgical ward standards
Arm Title
HELP Support System
Arm Type
Experimental
Arm Description
This arm will receive the HELP Support System intervention only
Arm Title
Family Support System
Arm Type
Experimental
Arm Description
This arm will receive the Family Support system intervention only
Arm Title
Combined Support Systems
Arm Type
Experimental
Arm Description
Participants randomized to this arm will receive both HELP- and family-based support system interventions
Intervention Type
Behavioral
Intervention Name(s)
Family Support System
Intervention Description
Family members and/or caregivers of patients will receive pagers, and alerts will provide recommendations for daily delirium screening and therapeutic activities. Protocols with associated activities will be provided to family members.
Intervention Type
Behavioral
Intervention Name(s)
HELP Support System
Intervention Description
A postoperative page will be sent, on behalf of participants, to the on-call HELP staff. The page will request early evaluation and enhanced therapeutic protocols for delirium prevention.
Primary Outcome Measure Information:
Title
Delirium
Description
Any positive delirium screen (yes/no) as determined by the long-form Confusion Assessment Method (n, 0-19)
Time Frame
morning postoperative day one through afternoon of postoperative day three
Secondary Outcome Measure Information:
Title
Delirium Severity
Description
For any patient with a positive delirium assessment, the associated severity score will be recorded using the Confusion Assessment Method Long Form Severity Score (n, 0-19, with higher number indicating more severe delirium)
Time Frame
morning postoperative day one through afternoon of postoperative day three
Title
Depressive symptoms as assessed by Hospitalized Anxiety and Depression Scale (HADS-D)
Description
Incidence (%) of positive screens (score ≥8) using the Hospitalized Anxiety and Depression Scale (HADS-D) (n, 0-21, 0 = normal, 21 = presence of severe depression symptoms)
Time Frame
baseline through postoperative day 2
Title
Anxiety symptoms as assessed by Hospitalized Anxiety and Depression Scale (HADS-A)
Description
Incidence (%) of positive screens (score ≥8) using the Hospitalized Anxiety and Depression Scale (HADS-A) (n, 0-21, 0 = normal, 21 = presence of severe anxiety symptoms)
Time Frame
baseline through postoperative day 3
Title
Falls
Description
Proportion of patients in each group (%) experiencing at least one fall
Time Frame
morning postoperative day one through afternoon of postoperative day three
Title
Length of Hospital Stay
Description
Total number of days (n) spent in the hospital, up to 30 days
Time Frame
morning of surgery until day of hospital discharge, up to 30 days
Title
Discharge Disposition
Description
Proportion of patients in each group (%) discharged somewhere other than home (e.g., Long-Term Care Facility), up to 30 days
Time Frame
day of hospital discharge, up to 30 days
Title
Delayed Discharge - Cognitive Impairment
Description
Proportion of patients in each group (%) experiencing delayed discharge, with the documented reason as cognitive impairment
Time Frame
day of hospital discharge, up to 30 days
Title
New non-surgical site infection
Description
Incidence (%) of any new non-surgical site infection while hospitalized
Time Frame
morning of surgery until day of hospital discharge, up to 30 days
Title
Multidrug resistant organism colonization
Description
Incidence (%) of any new multidrug resistant organism colonization
Time Frame
morning postoperative day one through 30 days after surgery
Title
Mortality
Description
Incidence (%)
Time Frame
within 30 days after surgery
Other Pre-specified Outcome Measures:
Title
HELP - duration of time
Description
Cumulative length of time spent with HELP team members
Time Frame
postoperative day one through postoperative day three
Title
HELP - visitation
Description
Proportion of patients successfully visited by the program
Time Frame
postoperative day one through postoperative day three
Title
HELP - time to evaluation
Description
Time until initial HELP evaluation
Time Frame
postoperative day one through postoperative day three
Title
Family intervention - duration of time
Description
Cumulative duration of time spent with family members/caretakers at the bedside
Time Frame
postoperative day one through postoperative day three
Title
Family intervention - proportion of daily tasks completed
Description
The proportion of family-based daily tasks successfully completed will be reported
Time Frame
postoperative day one through postoperative day three
Title
Family intervention - length of time, stimulating activity
Description
Cumulative length of time spent on prescribed stimulating activities
Time Frame
postoperative day one through postoperative day three
Title
Agreement - FAM-CAM and research-based CAM assessments
Description
Agreement will be assessed, via Cohen's kappa, between FAM-CAM and research-based CAM assessments.
Time Frame
postoperative day one through postoperative day three
Title
30-Day FAM-CAM Assessments
Description
Incidence (%) of positive FAM-CAM assessments post-discharge
Time Frame
day after discharge through 30 days postoperatively
Title
36-Item Short Form Survey
Description
Comprehensive survey that reports on overall health, functional status, physical/mental well-being, and pains (score range, for both overall scale and domain subscales: n, 0-100, 0 = worst score and 100 = best score in relation to the general state of health and quality of life)
Time Frame
30 days after hospital discharge
Title
PROMIS Cognitive Abilities (Short Form 4a)
Description
Subjective reporting of cognitive function
Time Frame
30 days postoperatively
Title
Hospital Readmission
Description
Incidence (%) of hospital readmission
Time Frame
within 30 days after discharge
10. Eligibility
Sex
All
Minimum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age ≥ 70 years of age
Major non-cardiac, non-intracranial neurologic, and non-major vascular surgery
Anticipated length of stay at least 72 hours
At least one family member, or caretaker, available on each of the first three postoperative days for trial operations
Exclusion Criteria:
Emergency surgery
Severe cognitive impairment (precluding ability to perform delirium assessments)
Planned postoperative ICU admission
Non-English speaking
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Phillip E Vlisides, MD
Organizational Affiliation
University of Michigan
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Michigan Medical School
City
Ann Arbor
State/Province
Michigan
ZIP/Postal Code
48109
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
32934794
Citation
Vlisides PE, Ragheb JW, Leis A, Schoettinger A, Hickey K, McKinney A, Brooks J, Zierau M, Norcott A, Yang S, Avidan MS, Min L. Recommendations and Alerting for Delirium Alleviation in Real-Time (RADAR): Protocol for a pilot randomized controlled trial. F1000Res. 2019 Sep 24;8:1683. doi: 10.12688/f1000research.20597.2. eCollection 2019.
Results Reference
derived
Learn more about this trial
Recommendations and Alerting for Delirium Alleviation in Real-Time (RADAR)
We'll reach out to this number within 24 hrs